Accelerated & Efficient Drug Development

Minerva Imaging is a scientifically driven CRO founded in 2011.
Our focus is on the use of advanced oncology models and molecular imaging for translational cancer research and drug development.

Our services

Oncology

We have extensive experience in design and execution of pre-clinical studies for drug development within oncology.

Read more

Radionuclide Therapy

We have substantial experience in performing studies with targeted radionuclide therapy in oncology.

Read more

Molecular Imaging

Building on more than two decades of research in Nuclear Medicine we are proficient in conducting molecular imaging.

Read more

Cardiovascular Disease

We have in-depth knowledge in cardiovascular disease and advanced imaging to study drug interventions.

Read more

We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers.

Optimal results require attention to details

We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers. Our competences build on more than two decades of research within oncology and molecular imaging performed at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.

Read about us

Latest news

November 6th 2018

EORTC-NCI-AACR 2018

Minerva Imaging will attend the EORTC-NCI-AACR 2018, November 13-16, 2018, Dublin, Ireland.

Read story
October 3rd 2018

EANM 2018 Congress in Düsseldorf/Germany

Minerva Imaging will attend the EANM 2018, October 13-17, 2018, Düsseldorf.

Read story
March 15th 2018

Poster presentations at the AACR annual meeting 2018

Minerva Imaging will attend the AACR Annual Meeting 2018, April 14-18.

Read story
January 18th 2018

AACR-SNMMI Joint Conference

Minerva Imaging to present at the third AACR-SNMMI joint conference, February 14-17, 2018, San Diego.

Read story